Literature DB >> 18728065

Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry.

T Shiga1, N Hagiwara, H Ogawa, A Takagi, M Nagashima, T Yamauchi, Y Tsurumi, R Koyanagi, H Kasanuki.   

Abstract

OBJECTIVE: To determine the incidence of sudden cardiac death (SCD) according to left ventricular ejection fraction (LVEF) in survivors of myocardial infarction (MI) in the primary percutaneous coronary intervention (PCI) era.
DESIGN: A multicentre observational prospective registered cohort study.
SETTING: 18 medical centres in Japan. PATIENTS: 4122 consecutive patients (mean age 66 (SD 12) years, 73.7% male) with acute MI, who were discharged alive. MAIN OUTCOME MEASURES: The primary end-point was SCD, and a secondary end-point was death from any cause.
RESULTS: Patients were categorised into three groups: LVEF >40% (n = 3416), LVEF < or =40% and >30% (n = 507) and LVEF < or =30% (n = 199). Among all patients, 77.8% received PCI and 3.7% received coronary artery bypass graft surgery. During an average follow-up of 4.1 years, SCD was 1.2% and mortality was 13.1%. Patients with LVEF < or =30% and LVEF < or =40% and >30% were at increased risk for SCD (HR 5.99, 95% CI 2.73 to 13.14, p<0.001, HR 3.37, 95% CI 1.74 to 6.50, p<0.001, respectively), and mortality (HR 3.85, 95% CI 2.96 to 5.00, p<0.001, HR 2.06, 95% CI 1.66 to 2.57, p<0.001, respectively), compared to patients with LVEF >40%. Kaplan-Meier estimates of SCD in patients with LVEF < or =30% were 2.9%, 5.1% and 5.1% at 1, 3 and 5 years, respectively.
CONCLUSION: There is a low incidence of SCD in survivors of MI in the primary PCI era, although LVEF is a predictor of increased risk for SCD.

Entities:  

Mesh:

Year:  2008        PMID: 18728065     DOI: 10.1136/hrt.2008.145243

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  21 in total

1.  Japan Implantable Devices in Coronary Artery Disease (JID-CAD) study design.

Authors:  Akihiko Shimizu; Takeshi Mitsuhashi; Takashi Nitta; Hideo Mitamura; Takashi Kurita; Haruhiko Abe; Yuji Nakazato; Naokata Sumitomo; Kazushige Kadota; Kazuo Kimura; Ken Okumura
Journal:  J Arrhythm       Date:  2014-09-12

2.  Towards a better risk stratification for sudden cardiac death in patients with structural heart disease.

Authors:  K Kraaier; P M J Verhorst; P F H M van Dessel; A A M Wilde; M F Scholten
Journal:  Neth Heart J       Date:  2009-03       Impact factor: 2.380

3.  Thyroid-stimulating hormone within the normal range and risk of major adverse cardiovascular events in nonischemic dilated cardiomyopathy patients with severe left ventricular dysfunction.

Authors:  Xiaofei Li; Yan Yao; Zhaoran Chen; Siyang Fan; Wei Hua; Shu Zhang; Xiaohan Fan
Journal:  Clin Cardiol       Date:  2018-12-20       Impact factor: 2.882

4.  Ventricular tachycardia and sudden death after primary PCI-reperfusion therapy: impact on primary prevention of sudden cardiac death.

Authors:  L Paranskaya; I Akin; T Chatterjee; A Ritz; P Paranski; T Rehders; H Ince; H Schneider; C A Nienaber; D Bänsch
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2011-12

5.  Electrocardiographic and clinical predictors separating atherosclerotic sudden cardiac death from incident coronary heart disease.

Authors:  Elsayed Z Soliman; Ronald J Prineas; L Douglas Case; Gregory Russell; Wayne Rosamond; Thomas Rea; Nona Sotoodehnia; Wendy S Post; David Siscovick; Bruce M Psaty; Gregory L Burke
Journal:  Heart       Date:  2011-07-20       Impact factor: 5.994

6.  Effect of left ventricular dysfunction and viral load on risk of sudden cardiac death in patients with human immunodeficiency virus.

Authors:  Brian S Moyers; Eric A Secemsky; Eric Vittinghoff; Joseph K Wong; Diane V Havlir; Priscilla Y Hsue; Zian H Tseng
Journal:  Am J Cardiol       Date:  2014-01-16       Impact factor: 2.778

7.  Clinical practice of defibrillator implantation after myocardial infarction: impact of implant time: results from the PreSCD II registry.

Authors:  Heinz Völler; Wolfram Kamke; Helmut U Klein; Michael Block; Rona Reibis; Sven Treusch; Klaus Contzen; Karl Wegscheider
Journal:  Europace       Date:  2010-11-30       Impact factor: 5.214

8.  Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy.

Authors:  Mohamad El Moheb; Johny Nicolas; Assem M Khamis; Ghida Iskandarani; Elie A Akl; Marwan Refaat
Journal:  Cochrane Database Syst Rev       Date:  2018-12-08

9.  Comparison of 2-year outcomes between primary and secondary prophylactic use of defibrillators in patients with coronary artery disease: A prospective propensity score-matched analysis from the Nippon Storm Study.

Authors:  Yusuke Kondo; Takashi Noda; Yasunori Sato; Marehiko Ueda; Takashi Nitta; Yoshifusa Aizawa; Tohru Ohe; Takashi Kurita
Journal:  Heart Rhythm O2       Date:  2021-01-07

10.  Almanac 2011: Acute Coronary Syndromes. The National Society Journals Present Selected Research that has Driven Recent Advances in Clinical Cardiology.

Authors:  Charles Knight; Adam D Timmis
Journal:  Mater Sociomed       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.